The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 08, 2019
Filed:
Dec. 05, 2018
Applicant:
Santen Pharmaceutical Co., Ltd., Osaka-shi, Osaka, JP;
Inventors:
Kenji Kawashima, Osaka, JP;
Yusuke Yamazaki, Ikoma, JP;
Shinji Takaoka, Ikoma, JP;
Daisuke Shii, Osaka, JP;
Tomoko Oda, Ikoma, JP;
Takahiro Matsuyama, Ikoma, JP;
Assignee:
SANTEN PHARMACEUTICAL CO., LTD., Osaka-Shi, Osaka, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 241/44 (2006.01); C07D 403/12 (2006.01); A61K 31/498 (2006.01); A61K 31/5377 (2006.01); A61K 31/675 (2006.01); A61P 27/02 (2006.01); A61P 29/00 (2006.01); C07F 9/6509 (2006.01);
U.S. Cl.
CPC ...
C07D 241/44 (2013.01); A61K 31/498 (2013.01); A61K 31/5377 (2013.01); A61K 31/675 (2013.01); A61P 27/02 (2018.01); A61P 29/00 (2018.01); C07D 403/12 (2013.01); C07F 9/650994 (2013.01);
Abstract
The present invention relates to defined quinoxalin-2-one compounds or a pharmaceutically acceptable salt or a hydrate or a solvate thereof. The compounds, salts or hydrates have a glucocorticoid receptor agonist activity, and are useful as a medicine, in particular as a prophylactic or therapeutic agent for a glucocorticoid receptor related disease.